Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Sponsor
Boston Scientific Corporation
Study ID
NCT06553625
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Radiofrequency Ablation — DEVICE
    Radiofrequency Ablation used in the central nervous system (CNS) in functional neurosurgery

Study Details

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Key Dates

First listed
Aug 14, 2024
Start date
Jan 29, 2024
Status verified
Jul 2026
Primary completion
Dec 31, 2035
Completion
Dec 31, 2035

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Boston Scientific Radiofrequency Ablation Systems
    Subjects treated with Boston Scientific commercially approved radiofrequency (RF) ablation systems in the central nervous system (CNS).

Primary Outcome Measure

Change in patient's quality of life (QoL) during the study as compared with baseline [ Time Frame: Up to 24-Months ]

Central Contacts

Find similar trials

Nationwide
Parkinson's disease trialsNeurology trialsBrain disorders trials

Related Studies